Navigation Links
Concordia University to build innovative centre for health research and training
Date:10/15/2009

This release is available in French.

Montreal/October 14, 2009 Judith Woodsworth, President and Vice-Chancellor of Concordia University is delighted to announce the creation of the PERFORM Research Centre. The acronym PERFORM stands for Prevention, Evaluation, Rehabilitation, FORMation. The Centre will become a reality thanks to a grant of $34,972,317 from the Federal and Provincial Governments, through the Knowledge Infrastructure Program.

The PERFORM Centre will be a multi-disciplinary centre located on the Loyola campus (7141 Sherbrooke St. West), bringing together mainly researchers from the field of Exercise Science specializing in behavioral medicine and clinical exercise physiology. They will work in close collaboration with hospitals and university health centres in the Montreal area but also with international partners.

"The PERFORM Centre will be unique in Canada allowing Concordia University to reinforce its world leadership position in the field of exercise physiology and athletic therapy", says Woodsworth. "It will comprise research into the benefits of physical activity and nutrition, the training of therapists and the delivery of clinical evaluation and rehabilitation services to Montrealers".

The centre will be built at the southern end of the Loyola Campus, connecting with the existing sports and recreation facilities, and measuring almost 12,000m2 in size. It will be the site of laboratories for specialized teaching and training in athletic therapy and cardiorespiratory physiology. It will also have therapeutic facilities for people with sports injuries or with health problems such as cancer, cardiac or respiratory diseases.

"One of the exceptional characteristics of the PERFORM Centre", says Woodsworth, "is its potential to add complementary expertise in research and professional formation to the existing health care network".

Construction of the Perform Centre will start in early 2010 and completed in 2011.


'/>"/>

Contact: Fiona Downey
Fiona.downey@concordia.ca
514-848-2424 x2518
Concordia University
Source:Eurekalert

Related biology news :

1. A world-first in solar technology unveiled at Concordia University
2. Concordia University leads academic team for national Cellulosic Biofuels Network
3. Concordia University receives more than $22 million for genomics research
4. Concordia University to construct new building for genomics research
5. A study by the MUHC and McGill University opens a new door to understanding cancer
6. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
7. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
8. Bioengineers at University of Pennsylvania devise nanoscale system to measure cellular forces
9. Binghamton University researchers investigate evolving malaria resistance
10. Antioxidant to retard wrinkles discovered by Hebrew University researcher
11. Society for General Microbiology 161st Meeting, University of Edinburgh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... DIEGO , June 22, 2016 ... that will allow them to produce up to ... from one lot within one week. These high-quality, ... time laboriously preparing cells and spend more time ... possible through a proprietary, high-volume manufacturing process that ...
Breaking Biology Technology: